PCN2 PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONISTS IN PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS WITH CANCER TREATED IN A HOSPITAL OUTPATIENT SETTING
Abstract
Authors
C Craver J Gayle S Balu D Buchner